TrumpRX запущен до 31 января 2026 года?
TrumpRX запущен до 31 января 2026 года?
Да
$303,218 Объем
$303,218 Объем
Jan 31, 2026
Да
$303,218 Объем
$303,218 Объем
Jan 31, 2026
TrumpRx (https://trumprx.gov/) is scheduled to launch in January 2026 and is intended to help consumers access lower-cost medications by directing them to manufacturers’ direct-to-consumer purchasing channels.
This market will resolve to "Yes" if TrumpRx.gov becomes publicly accessible in a form that allows members of the public to search for and find medications by January 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."
To qualify, the site must be publicly accessible and operational in at least a limited capacity, meaning it functions in its intended portal role by allowing users to search for or view medications and be redirected to purchase them. Glitches or minor technical issues will not render the site non-functional, provided the core portal functionality remains available to the public.
Once the qualifying functionality goes live, the market will resolve to "Yes" immediately, regardless of any subsequent reversal, rollback, or withdrawal of access.
This market will resolve to "No" if TrumpRx.gov becomes permanently unavailable.
The primary resolution source for this market will be TrumpRx.gov; however, a consensus of credible reporting will also be used.
TrumpRx (https://trumprx.gov/) is scheduled to launch in January 2026 and is intended to help consumers access lower-cost medications by directing them to manufacturers’ direct-to-consumer purchasing channels.
This market will resolve to "Yes" if TrumpRx.gov becomes publicly accessible in a form that allows members of the public to search for and find medications by January 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."
To qualify, the site must be publicly accessible and operational in at least a limited capacity, meaning it functions in its intended portal role by allowing users to search for or view medications and be redirected to purchase them. Glitches or minor technical issues will not render the site non-functional, provided the core portal functionality remains available to the public.
Once the qualifying functionality goes live, the market will resolve to "Yes" immediately, regardless of any subsequent reversal, rollback, or withdrawal of access.
This market will resolve to "No" if TrumpRx.gov becomes permanently unavailable.
The primary resolution source for this market will be TrumpRx.gov; however, a consensus of credible reporting will also be used.TrumpRx (https://trumprx.gov/) is scheduled to launch in January 2026 and is intended to help consumers access lower-cost medications by directing them to manufacturers’ direct-to-consumer purchasing channels.
This market will resolve to "Yes" if TrumpRx.gov becomes publicly accessible in a form that allows members of the public to search for and find medications by January 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."
To qualify, the site must be publicly accessible and operational in at least a limited capacity, meaning it functions in its intended portal role by allowing users to search for or view medications and be redirected to purchase them. Glitches or minor technical issues will not render the site non-functional, provided the core portal functionality remains available to the public.
Once the qualifying functionality goes live, the market will resolve to "Yes" immediately, regardless of any subsequent reversal, rollback, or withdrawal of access.
This market will resolve to "No" if TrumpRx.gov becomes permanently unavailable.
The primary resolution source for this market will be TrumpRx.gov; however, a consensus of credible reporting will also be used.
This market will resolve to "Yes" if TrumpRx.gov becomes publicly accessible in a form that allows members of the public to search for and find medications by January 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."
To qualify, the site must be publicly accessible and operational in at least a limited capacity, meaning it functions in its intended portal role by allowing users to search for or view medications and be redirected to purchase them. Glitches or minor technical issues will not render the site non-functional, provided the core portal functionality remains available to the public.
Once the qualifying functionality goes live, the market will resolve to "Yes" immediately, regardless of any subsequent reversal, rollback, or withdrawal of access.
This market will resolve to "No" if TrumpRx.gov becomes permanently unavailable.
The primary resolution source for this market will be TrumpRx.gov; however, a consensus of credible reporting will also be used.
Открытие рынка: Nov 13, 2025, 5:50 PM ET
Объем
$303,218Дата окончания
Jan 31, 2026Открытие рынка
Nov 13, 2025, 5:50 PM ETResolver
0x65070BE91...Предложенный исход: Нет
Спор отсутствует
Окончательный исход: Нет
TrumpRx (https://trumprx.gov/) is scheduled to launch in January 2026 and is intended to help consumers access lower-cost medications by directing them to manufacturers’ direct-to-consumer purchasing channels.
This market will resolve to "Yes" if TrumpRx.gov becomes publicly accessible in a form that allows members of the public to search for and find medications by January 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."
To qualify, the site must be publicly accessible and operational in at least a limited capacity, meaning it functions in its intended portal role by allowing users to search for or view medications and be redirected to purchase them. Glitches or minor technical issues will not render the site non-functional, provided the core portal functionality remains available to the public.
Once the qualifying functionality goes live, the market will resolve to "Yes" immediately, regardless of any subsequent reversal, rollback, or withdrawal of access.
This market will resolve to "No" if TrumpRx.gov becomes permanently unavailable.
The primary resolution source for this market will be TrumpRx.gov; however, a consensus of credible reporting will also be used.
TrumpRx (https://trumprx.gov/) is scheduled to launch in January 2026 and is intended to help consumers access lower-cost medications by directing them to manufacturers’ direct-to-consumer purchasing channels.
This market will resolve to "Yes" if TrumpRx.gov becomes publicly accessible in a form that allows members of the public to search for and find medications by January 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."
To qualify, the site must be publicly accessible and operational in at least a limited capacity, meaning it functions in its intended portal role by allowing users to search for or view medications and be redirected to purchase them. Glitches or minor technical issues will not render the site non-functional, provided the core portal functionality remains available to the public.
Once the qualifying functionality goes live, the market will resolve to "Yes" immediately, regardless of any subsequent reversal, rollback, or withdrawal of access.
This market will resolve to "No" if TrumpRx.gov becomes permanently unavailable.
The primary resolution source for this market will be TrumpRx.gov; however, a consensus of credible reporting will also be used.TrumpRx (https://trumprx.gov/) is scheduled to launch in January 2026 and is intended to help consumers access lower-cost medications by directing them to manufacturers’ direct-to-consumer purchasing channels.
This market will resolve to "Yes" if TrumpRx.gov becomes publicly accessible in a form that allows members of the public to search for and find medications by January 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."
To qualify, the site must be publicly accessible and operational in at least a limited capacity, meaning it functions in its intended portal role by allowing users to search for or view medications and be redirected to purchase them. Glitches or minor technical issues will not render the site non-functional, provided the core portal functionality remains available to the public.
Once the qualifying functionality goes live, the market will resolve to "Yes" immediately, regardless of any subsequent reversal, rollback, or withdrawal of access.
This market will resolve to "No" if TrumpRx.gov becomes permanently unavailable.
The primary resolution source for this market will be TrumpRx.gov; however, a consensus of credible reporting will also be used.
This market will resolve to "Yes" if TrumpRx.gov becomes publicly accessible in a form that allows members of the public to search for and find medications by January 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."
To qualify, the site must be publicly accessible and operational in at least a limited capacity, meaning it functions in its intended portal role by allowing users to search for or view medications and be redirected to purchase them. Glitches or minor technical issues will not render the site non-functional, provided the core portal functionality remains available to the public.
Once the qualifying functionality goes live, the market will resolve to "Yes" immediately, regardless of any subsequent reversal, rollback, or withdrawal of access.
This market will resolve to "No" if TrumpRx.gov becomes permanently unavailable.
The primary resolution source for this market will be TrumpRx.gov; however, a consensus of credible reporting will also be used.
Объем
$303,218Дата окончания
Jan 31, 2026Открытие рынка
Nov 13, 2025, 5:50 PM ETResolver
0x65070BE91...Предложенный исход: Нет
Спор отсутствует
Окончательный исход: Нет
Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы